destructive cholecystitis, laparoscopic cholecystectomy, laparolift, SAPS II

Written by Bratchikov O.I., Tyuzikov I.A., Shumakova E.A., Gres A.A., Churaev S.A.

  UDK: 616.65-007.61-053.87-085.2:612.433,451 | Pages: 29–33 | Full text PDF | Open PDF 


Background. Research objective is an efficiency and safety analysis of different ways of treatment of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH), including androgen substitutive therapy.
Methods. The results of the survey and conservative treatment of 187 men with LUTS/BPH were analyzed. Monotherapy α1-blocker, 5α-reductase inhibitor and plant complex received 40, 35 and 30 patients, respectively. Another 40 people received combination therapy (α1-blocker and 5α-reductase inhibitor) and 42 patients with age-related hypogonadism additionally received the testosterone undecenoate.
Results. The efficacy of standard medical therapy without androgen status of patients was on average 70.2 %. Additional androgen substitutive therapy of testosterone with the undecanoate contributed significantly more pronounced therapeutic effect in hypogonadal men.
Conclusions. The study confirmed the high clinical and urodynamic efficacy and safety of a combination of standard treatment and androgen substitutive therapy in hypogonadal men with LUTS/BPH.

Links to authors:

O.I. Bratchikov1, I.A. Tyuzikov2, E.A. Shumakova1, A.A. Gres3, S.A. Churaev1
1 Kursk State Medical University (3 Karl Marks St. Kursk 305041 Russian Federation),
2 Clinic of Professor Kalinichenko (4/2 Butyrskaya St. Moscow 127015 Russian Federation),
3 Belorussian Medical Academy of Postgraduate Education (3/3 P. Brovki St. Minsk 220013 Republic of Belorussia)

1. Bratchikov O.I., Shumakova E.A., Khmaruk A.P., Mikhaylov D.V. Optimization of methods of medical treatment of patients with BPH // Kursk Scientific and Practical Bulletin ‘Man and His Health’. 2011. No. 3. P. 34–41.
2. Bratchikov O.I., Tyuzikov I.A. Shumakova E.A. [et al.]. Clinical and epidemiological correlation of age-related androgen deficiency and LUTS / BPH in men // Kursk Scientific and Practical Bulletin‘Man and His Health’. 2014. No. 4. P. 40–45.
3. Bratchikov O.I., Tyuzikov I.A., Shumakova E.A. [et al.]. Effect of different modes of pharmacotherapy for prostate volume and residual urine in men with LUTS / BPH depending on the androgenic status // Kursk Scientific and Practical Bulletin ‘Man and His Health’. 2015. No. 1. P. 10–17.
4. Popkov V.M., Bratchikov O.I., Blyumberg B.I. Clinical and diagnostic value of markers of cell renewal and endocrine cells in diseases of the prostate // Pacific Medical Journal. 2011. No. 1. P. 29–33.
5. Bratchikov O., Hambaryan A. Is the obstructive uropathy a sequence of vascular disorders in patients with BPH? // European urology supplements. 23 Annual EAU Congress. Milan, 2008. Vol. 7, Is. 3, P. 236.
6. Hafez B., Hafez E.S. Andropause: endocrinology, erectile dysfunction, and prostate pathophysiology // Arch. Androl. 2004. Vol. 50, No. 2. P. 45–68.
7. Haider A., Gooren L.J., Padungtod P., Saad F. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men // Andrologia. 2009. Vol. 41. P. 7–13.
8. Karazindiyanoğlu S., Cayan S. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism // Aging Male. 2008. Vol. 11, No. 3. P. 146–149.
9. Koritsiadis G., Stravodimos K., Mitropoulos D. Androgens and bladder outlet obstruction: a correlation with pressureflow variables in a preliminary study // BJU Int. 2008. Vol. 101. P. 1542–1546.
10. Lee J.H., Kim Y., Park Y.W., Lee D.G. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men // J. Sex. Med. 2014. Vol. 11, No. 5. P. 1309–1315.
11. Maserejian N.N., Chen S., Chiu G.R. Treatment status and progression or regression of lower urinary tract symptoms among adults in a general population sample // J. Urol. 2013. Vol. 9. pii: S0022–5347(13)04861–1. doi: 10.1016/j.juro.2013.07.005 [Epub ahead of print].
12. Shigehara K., Namiki M. Late-onset hypogonadism syndrome and lower urinary tract symptoms // Korean J. Urol. 2011. Vol. 52, No. 10. P. 657–663.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.